tiprankstipranks
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
US Market
BVAXF
BioVaxys Technology
RESEARCH TOOLSreports

BioVaxys Technology (BVAXF) Financial Statements

Compare
32 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently $1.89M. The company's EPS TTM is $; its P/E ratio is -1.60; BioVaxys Technology is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 24Jan 24Jan 23Jan 22Jan 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating IncomeC$ -3.30MC$ -2.40MC$ -4.08MC$ -6.44MC$ -1.10M
EBITDAC$ -3.95MC$ -7.69MC$ 0.00C$ -6.42MC$ -1.09M
Net IncomeC$ -3.95MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17M
Balance Sheet
Cash & Short-Term InvestmentsC$ 211.81KC$ 977.00C$ 141.90KC$ 593.12KC$ 2.42M
Total AssetsC$ 1.30MC$ 113.48KC$ 865.56KC$ 8.50MC$ 10.46M
Total DebtC$ 68.08KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -143.73KC$ -977.00C$ -141.90KC$ -593.12KC$ -2.42M
Total LiabilitiesC$ 3.22MC$ 3.49MC$ 1.64MC$ 326.86KC$ 900.09K
Stockholders' EquityC$ -1.92MC$ -3.37MC$ -773.53KC$ 8.18MC$ 9.56M
Cash Flow
Free Cash FlowC$ -2.92MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Operating Cash FlowC$ -1.86MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Investing Cash FlowC$ -1.06MC$ 0.00C$ 0.00C$ 0.00C$ 61.36K
Financing Cash FlowC$ 3.13MC$ 917.10KC$ 1.11MC$ 3.44MC$ 3.35M
Currency in CAD

BioVaxys Technology Earnings and Revenue History

Income Statement >

BioVaxys Technology Debt to Assets

Balance Sheet >

BioVaxys Technology Cash Flow

Cash Flow >

BioVaxys Technology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >